- Upregulation of DOPAMINE RECEPTORS - High Quality [DOWNLOAD] (Patreon)
Downloads
Some files exceed the archive size limit and weren't saved: 1 file. Please note these limits are in place to keep this site running long term, without costing a fortune. You can favorite the creator though, certain milestones increase the limit.
Content
- PRE-RELEASE - (05.11.2021)- PUBLIC RELEASE - (21.08.2022)Dopamine is one of the primary neurotransmitters, commonly known as a "pleasure compound" or "molecule of addiction." Dopamine regulates reward-motivated behavior, meaning it drives/motivates us to pursue potential rewards. Moreover, it determines primary brain functions such as memorization, concentration, and communication skills and regulates the functioning of the immune system and insulin production. Dopamine act through dopamine receptors such as D1-5 adrenergic alpha and B1. Rapid and prolonged fluctuations in dopamine levels and overstimulation of the receptors can disrupt dopamine secretion and downregulate corresponding receptors - decrease their count & sensitivity. Primary culprits leading to disorders on the dopaminergic path are: regular specific drug and/or medication intake, porn watching, gambling, consuming junk food, excessive use of social media, lack of sleep, and poor lifestyle.
- Upregulation of Dopamine Receptors - is a composition of binaural beats, brown noise, and soothing auditory stimulation that allows the body & brain to improve the responsiveness of dopamine receptors and promote their expression. As a result, it optimizes dopamine activity, thus increasing motivation, libido, and overall energy, improving well-being, and the ability to focus, learn and communicate while preventing fatigue, procrastination, and depression.
For best results, listen to 2-3x daily.
Worth knowing: Prolactin secretion in the pituitary is generally suppressed by dopamine - prolactin antagonists. Hyperprolactinemia (excessive prolactin production) may occur due to, i.a., low dopamine activity (induced by, e.g., dopamine-inhibiting drugs [D2 receptor antagonists]).